How Can HIV Spread? Transmission Routes Explained

HIV spreads through a small number of well-defined routes, all involving direct contact with specific body fluids: blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids, and breast milk. Sexual contact accounts for the vast majority of new infections worldwide, followed by sharing injection equipment, mother-to-child transmission during pregnancy or breastfeeding, and rare occupational exposures like needlestick injuries. The virus does not survive well outside the body, which is why casual contact, insect bites, and shared surfaces pose no risk. But within those established routes, the actual probability of transmission varies enormously depending on the type of exposure, viral load, and a handful of biological factors that most people never hear about.

Sexual Transmission and Per-Act Risk

Sex is the primary way HIV moves between people, but the risk from a single sexual act is not uniform across all types of sex. Receptive anal intercourse carries the highest per-act probability among sexual exposures. A systematic review and meta-analysis estimated the per-act risk of unprotected receptive anal intercourse at roughly 1.4%, with the per-partner risk climbing to about 40% over the course of an ongoing sexual relationship without condoms.¹ A separate meta-analysis placed the per-act estimate for receptive anal intercourse at about 1.7%, though with wide confidence intervals.² The rectal lining is thin, rich in immune cells the virus targets, and prone to micro-tears during intercourse, all of which help explain the elevated risk.

Vaginal intercourse carries a lower but still meaningful per-act risk. In high-income countries, the pooled estimate is around 0.08% per act for the receptive partner (male-to-female) and about 0.04% per act for the insertive partner (female-to-male).² Those numbers rise substantially in low-income settings, likely reflecting higher rates of untreated sexually transmitted infections, higher community viral loads, and differences in circumcision prevalence. For insertive anal intercourse, a systematic review placed the per-act risk at about 11 per 10,000 exposures.³

Oral sex sits at the bottom of the risk spectrum. The estimated transmission risk for both receptive and insertive oral sex is very low, with confidence intervals that include zero.³ That does not mean zero risk in every scenario, but documented cases of oral-only transmission are rare enough that researchers have difficulty measuring the probability with any precision.

Why Viral Load Changes Everything

The per-act numbers above reflect averages across populations where most people living with HIV were untreated. Once antiretroviral therapy enters the picture, the math shifts dramatically. The PARTNER2 study followed gay couples where one partner was HIV-positive and on suppressive treatment, tracking them through tens of thousands of acts of condomless sex. Among couples where the HIV-positive partner maintained a viral load below 200 copies per milliliter, there were zero linked transmissions. The estimated rate was so low the researchers described it as equivalent to roughly one transmission per 435 couple-years of condomless sex, and even that was just the upper boundary of the confidence interval, not an observed event.⁴

A broader systematic review extended this finding beyond just fully suppressed individuals. It concluded there is almost zero risk of sexual transmission at viral loads below 1,000 copies per milliliter.⁵ This evidence underpins the public health message known as U=U, or “Undetectable equals Untransmittable,” which has reshaped HIV prevention counseling and, for many people living with HIV, their daily experience of stigma.

The flip side of this relationship is equally important. During the first weeks after someone acquires HIV, before they know they are infected, viral load skyrockets. Infectiousness during this acute phase may be as much as 26 times greater than during the long chronic phase that follows.⁶ A meta-analysis that tried to untangle how much of this increased transmission was explained by viral load alone found that the observed transmission rates during primary infection were actually higher than viral load numbers alone would predict, suggesting other biological factors at play during those early weeks.⁷ During acute infection, viral concentrations in semen and blood are both extremely high, providing a biological basis for the spike in transmission risk.⁸

Blood-Borne Transmission

Sharing injection equipment is one of the most efficient ways HIV spreads. When people who inject drugs share syringes, the key variable is how much blood the syringe retains after use. High dead-space syringes, which hold over a thousand times more residual blood than low dead-space designs, are associated with significantly higher HIV prevalence among people who share them. One study found HIV prevalence of 16% among people who had shared a high dead-space syringe compared with 5% among those who had not, with the odds of infection roughly two and a half times higher for those who shared.⁹ Mathematical models and cross-sectional surveys support the conclusion that switching to low dead-space syringes could prevent injection-driven HIV epidemics.¹⁰

Blood transfusion was once a significant transmission route, but modern screening has made it extraordinarily rare in countries with robust testing infrastructure. Nucleic acid testing can detect HIV in donated blood well before antibodies develop, though a narrow “window period” still exists. One analysis of individual-donation nucleic acid testing estimated the residual risk of an HIV-positive donation slipping through at roughly 1 in 479,000.¹¹ An earlier Italian study estimated the pre-NAT residual risk at about 1 in 435,000 for HIV using antibody screening alone, with nucleic acid testing expected to cut that further by half.¹² Despite these advances, pooled nucleic acid testing has not completely eliminated the window period for detection during very early seroconversion.¹³

Mother-to-Child Transmission

HIV can pass from mother to child during pregnancy, labor and delivery, or breastfeeding. Without any intervention, the combined risk across all three stages is substantial, but antiretroviral treatment given during pregnancy has been one of the greatest success stories in HIV prevention, dramatically reducing transmission rates. All HIV-positive pregnant women are now recommended to receive combination antiretroviral therapy regardless of their clinical stage.¹⁴

Breastfeeding remains a particularly challenging piece of this puzzle, especially in settings where safe alternatives to breast milk are not reliably available. Despite progress in preventing transmission around the time of delivery, breastfeeding still contributes to roughly half of pediatric HIV infections recorded globally each year.¹⁵ Transmission through breast milk can happen at any point during lactation, and the cumulative risk grows with the duration of breastfeeding. Higher maternal viral load in both blood and breast milk is strongly linked to higher transmission risk, as is poor breast health, such as cracked nipples or mastitis.¹⁶ In the PROMISE trial, maternal viral load during breastfeeding was strongly associated with infant infection among mothers receiving antiretroviral treatment.¹⁷

Some research has also suggested that exclusive breastfeeding may carry lower transmission risk than mixed feeding, where an infant receives both breast milk and other foods or formula. The hypothesis is that mixed feeding may compromise the infant’s gut lining, creating more opportunity for the virus to cross mucosal barriers.¹⁶

Occupational Exposure

Healthcare workers face a small but real risk from needlestick and sharps injuries. The average per-event risk of HIV transmission from a contaminated needlestick is generally cited at around 0.3%, but this average obscures wide variation depending on the circumstances. A landmark case-control study of healthcare workers who seroconverted after needlestick injuries found that deep injuries carried 15 times the odds of seroconversion compared with superficial ones, and visible blood on the device increased the odds about sixfold. Injuries involving needles that had been placed directly in a source patient’s vein or artery also carried higher risk, as did exposure to a source patient with advanced disease and presumably high viral load.¹⁸

Post-exposure prophylaxis, or PEP, is a 28-day course of antiretroviral drugs taken as soon as possible after a potential exposure, ideally within hours. That same case-control study found that healthcare workers who took zidovudine after their exposure had roughly 81% lower odds of seroconversion.¹⁸ Despite its effectiveness, adherence to the full PEP course remains a problem in practice. One study found that only about a quarter of healthcare workers who started PEP completed the full 28 days, though completion rates were much higher when the source patient’s HIV status was confirmed positive.¹⁹

Other Sexually Transmitted Infections as Amplifiers

One of the most underappreciated factors in HIV transmission is the role of other sexually transmitted infections. STIs that cause ulcers or inflammation dramatically increase the efficiency of HIV transmission by both making an HIV-positive person more infectious and making an HIV-negative person more susceptible.²⁰ Genital ulcers disrupt the skin and mucosal barriers, and the inflammatory immune response to any STI recruits exactly the types of immune cells that HIV targets, concentrating them at the site of sexual contact.

Herpes simplex virus type 2 (HSV-2) deserves special attention because it is extremely common and lifelong. An updated meta-analysis found that existing HSV-2 infection nearly tripled the risk of acquiring HIV among general populations. A new HSV-2 infection was associated with an even steeper increase, roughly a fivefold jump in HIV risk.²¹ Across sub-Saharan Africa, where both viruses are highly prevalent, between a quarter and a third of HIV infections may be attributable to HSV-2 at the population level.²²

How Circumcision Affects Male Susceptibility

Three large randomized trials conducted in sub-Saharan Africa demonstrated that male circumcision reduces heterosexual HIV acquisition in men by at least 60%.²³ The foreskin appears to create a warm, moist environment underneath that promotes microbial growth and chronic low-level immune activation. That immune activation draws in the very CD4+ T cells HIV needs to infect, concentrating them near the surface. Research on uncircumcised men found that those who later acquired HIV had lower levels of neutralizing antibodies in the foreskin and higher levels of inflammatory markers before infection, suggesting the local immune environment was primed for HIV entry before exposure ever occurred.²⁴

It is worth noting that circumcision’s protective effect has been clearly demonstrated for heterosexual male-to-female sex. The evidence is weaker and less consistent for men who have sex with men and for female partners. This is not a standalone prevention method; health authorities recommend it as one component within a broader prevention strategy.

Routes That Do Not Transmit HIV

Given how feared HIV transmission once was, and in many places still is, it is worth being specific about what does not spread the virus. Saliva is not a transmission route. Lab studies have shown that saliva rapidly destroys the immune cells HIV depends on for replication, achieving more than a 90% kill rate and producing a 10,000-fold or greater reduction in viral multiplication. The primary mechanism is surprisingly simple: saliva is hypotonic, meaning its low salt concentration causes infected cells to burst open and die.²⁵

Mosquitoes do not transmit HIV. Studies have shown that HIV is destroyed inside the mosquito’s gut within one to two days as the blood meal is digested. Because the virus cannot survive long enough to replicate and reach the salivary glands, the biological cycle that allows mosquitoes to spread diseases like malaria simply does not work for HIV.²⁶

HIV is also fragile on environmental surfaces and in water. In tap water at room temperature, the virus loses 90% of its infectivity within one to two hours and 99.9% within eight hours.²⁷ This fragility is why you cannot get HIV from toilet seats, swimming pools, shared utensils, hugging, or any other form of casual contact. The virus requires a direct path from an infected person’s body fluids into another person’s bloodstream or mucous membranes.

Prevention Tools Beyond Condoms

Condoms remain highly effective at blocking sexual transmission when used consistently, but the modern prevention toolkit has expanded. Pre-exposure prophylaxis, or PrEP, involves an HIV-negative person taking antiretroviral medication on an ongoing basis to prevent infection. PrEP works by building up drug concentrations in the tissues where HIV would first try to establish itself. Research on tissue-level drug concentrations has shown that for vaginal exposure, the amount of active drug in cervicovaginal fluid needs to reach a certain threshold to be protective, and different delivery methods achieve this differently.²⁸ Intravaginal rings containing tenofovir have shown significantly higher drug concentrations and anti-HIV activity in cervicovaginal fluid compared with oral PrEP.²⁹ Long-acting injectable PrEP, given every two months, has also entered clinical practice and removes the daily adherence challenge entirely.

Post-exposure prophylaxis is the emergency option, recommended to be started within 36 to 72 hours of a possible exposure and continued for 28 days. PEP is used both in occupational settings, as with needlestick injuries, and after sexual exposure. The vast majority of nonoccupational PEP prescriptions are for sexual exposures.

HIV-1 Versus HIV-2

Most public discussion of HIV refers to HIV-1, which causes the vast majority of infections globally. HIV-2, found primarily in parts of West Africa, shares the same basic transmission routes and can also cause AIDS. However, HIV-2 is markedly less transmissible and less likely to progress to AIDS.³⁰ People with HIV-2 tend to have lower viral loads, which is a large part of why the virus spreads less efficiently. Understanding the differences between the two has provided researchers with useful clues about what makes a virus more or less dangerous after it jumps into humans.

Both viruses originated from simian immunodeficiency viruses in African primates. HIV-1 crossed into humans from chimpanzees in what is now southeastern Cameroon, with one particular transmission event giving rise to group M, the lineage responsible for the global pandemic.³¹ Phylogenetic analysis has identified at least four separate cross-species jumps that produced different lineages of HIV-1, and one or two of those may have passed through gorillas as an intermediate host before reaching humans.³² Most of these jumps produced viruses that spread only in limited circles. The one that became a pandemic was, in evolutionary terms, a spectacularly unlikely event that happened to find the right combination of viral properties and human population dynamics.

Criminalization and Structural Drivers

The biology of transmission does not exist in a vacuum. How societies respond to HIV affects who gets tested, who stays on treatment, and ultimately who transmits the virus. At least 130 countries have criminalized people living with HIV at some point during the epidemic, using either HIV-specific statutes or general criminal laws covering assault, bodily harm, or even attempted murder.³³ Many of these laws were written in the 1980s and 1990s, when effective treatment did not exist and the science of transmission was far less settled. They often do not reflect current evidence, including the fact that a person on effective treatment poses essentially no sexual transmission risk. Criminalization has been widely criticized by public health experts for discouraging testing and disclosure, which paradoxically can increase transmission by leaving more people undiagnosed and untreated.

1
International Journal of Epidemiology. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention
2
The Lancet Infectious Diseases. Systematic review of HIV-1 transmission probabilities: a systematic review and meta-analysis
3
PubMed Central. Estimating per-act HIV transmission risk: a systematic review
4
The Lancet. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER2)
5
PubMed Central. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review
6
PubMed Central. Role of acute and early HIV infection in the sexual transmission of HIV
7
PubMed Central. Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis
8
PubMed Central. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection
9
PubMed Central. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users
10
PubMed. Low dead-space syringes for preventing HIV among people who inject drugs: promise and barriers
11
PubMed. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa
12
PubMed. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy
13
PubMed. Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor
14
Cell Press / ScienceDirect. HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity
15
PubMed Central. Mother-to-Child Transmission of HIV Through Breastfeeding Improving Awareness and Education: A Short Narrative Review
16
PubMed Central. Breast-feeding and Transmission of HIV-1
17
PubMed Central. Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Breastfeeding in the PROMISE Postpartum Component
18
PubMed. A case-control study of HIV seroconversion in health care workers after percutaneous exposure
19
medRxiv. HIV post-exposure prophylaxis adherence due to needle stick and sharp injuries
20
Nature Reviews Microbiology. The role of sexually transmitted diseases in HIV transmission
21
PubMed Central. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis
22
PubMed Central. Contribution of sexually transmitted infections to the sexual transmission of HIV
23
PubMed Central. The biology of how circumcision reduces HIV susceptibility: broader implications for the prevention field
24
PLOS Pathogens. HIV Acquisition Is Associated with Increased Antimicrobial Peptides and Reduced HIV Neutralizing IgA in the Foreskin Prepuce of Uncircumcised Men
25
PubMed. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes
26
PubMed. Can mosquitoes transmit AIDS?
27
PubMed Central. Survival of human immunodeficiency virus (HIV), HIV-infected lymphocytes, and poliovirus in water
28
PubMed Central. Pre-exposure Prophylaxis for HIV Infection: How Antiretroviral Pharmacology helps to Monitor and Improve Adherence
29
PubMed Central. Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration
30
PubMed. Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis
31
PubMed Central. Origins of HIV and the AIDS pandemic
32
PubMed Central. The evolution of HIV-1 and the origin of AIDS
33
PubMed Central. Punishing Vulnerability Through HIV Criminalization